Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

NCT01888601

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Princess Alexandra Hospital NHS Trust Harlow, Essex, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, Select Region, United Kingdom
  • Ashford and St Peter's Hospitals NHS Foundation Trust Chertsey, Surrey, United Kingdom
View all 18 locations
View Trial Details
Active, not recruiting

Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer

NCT05195632

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Peking University First Hospital Beijing, China
  • The First Hospital of Jilin University Changchun, China
View all 34 locations
View Trial Details
Active, not recruiting

NADIM II: Neo-Adjuvant Immunotherapy

NCT03838159

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital General de Alicante Alicante, Spain
  • ICO Badalona Badalona, Barcelona, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 25 locations
View Trial Details
Active, not recruiting

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

NCT02486718

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • Compassionate Cancer Care Medical Group, Inc Fountain Valley, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 154 locations
View Trial Details
Active, not recruiting

Osimertinib In EGFR Mutant Lung Cancer

NCT03586453

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors

NCT02589522

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
View Trial Details

Related conditions